Veterinary CRO Market to Reach at 8.1% CAGR & to Hit $1.33 Bn By 2026

Pune, Maharashtra, India, September 17 2020 (Wiredrelease) Allied Analytics –:Rise in ownership of companion animals, increase in animal health expenditure, and surge in prevalence of various diseases among companion animals have boosted the growth of the global veterinary CRO market

“Veterinary CRO Market by Service Type (Clinical Trials, Toxicology, Market Authorization & Regulatory Support and Others), Application (Dogs, Cats, and Others), End User (Oncology, Infectious Diseases, Neurology and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026″. According to the report, the global veterinary CRO industry was pegged at $714 million in 2018, and is projected to $1.33 billion by 2026, registering a CAGR 8.1% from 2019 to 2026.

Download Free Sample Report with Details COVID-19 Impact@ https://www.alliedmarketresearch.com/request-sample/6265

Major market players-

The global veterinary CRO market is highly competitive, and the prominent players in the market have adopted various strategies for garnering maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Charles River Laboratories, Inc., Clinvet, KLIFOVET AG, Löhlein & Wolf Vet Research, Oncovet Clinical Research, ONDAX Scientific, Triveritas, Veterinary Research Management (VRM) Ltd, VetPharm, Inc., and VETSPIN SRL.

Clinical trials segment dominated the market:-

The clinical trials segment held the largest share in 2018, contributing to nearly one-third of the market, owing to presence of stringent government regulations that support clinical trials of veterinary drugs. Moreover, the segment is expected to portray the fastest CAGR of 8.9% during the forecast period.

Neurology segment to manifest fastest growth through 2026:-

The neurology segment is anticipated to register the fastest CAGR of 9.0% during the study period, owing to surge in awareness related to early diagnosis of neurology disorders in companion animals for better treatment. However, the infectious diseases segment held the largest share in 2018, accounting for one-fifth and is expected to maintain its dominance throughout the study period.

North America held the lion’s share:-

The market across North America held the largest share in 2018, accounting for more than one-third of the market, owing to rise in ownership of companion animals and surge in animal healthcare expenditure in the region. However, the market across Asia-Pacific is expected to manifest the fastest CAGR of 9.4% from 2019 to 2026, owing to surge in awareness related to use of awareness among individuals related to treatment and early diagnosis of diseases in companion animals.

For Purchase Enquiry@ https://www.alliedmarketresearch.com/purchase-enquiry/6265

Similar Reports With COVID-19 Analysis:

Herbal Medicines Market by Product Type (Medicinal Part, Medicine Function, and Active Ingredient) and by Application (Western Herbalism, Traditional Chinese Medicine, and Others) – Global Opportunity Analysis and Industry Forecast, 2020-2027

Ayurvedic Market by Product (Healthcare, Personal Care, Skin Care, Hair Care, Oral Care, and Drugs) and Distribution Channel (Supermarkets, Pharmacies, Departmental Stores, Beauty Spa/Salon, Internet Retailing, and Specialty Stores) – Global Opportunity Analysis and Industry Forecast, 2020-2027

Human Growth Hormone (hGH) Market by Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Oral), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2019–2026

Protein Sequencing Market by Product and Service (Reagents & Consumables, Instruments, Analysis Products, Protein Sequencing Services, and Others), Technology (Mass Spectrometry, and Edman Degradation), and Application (Academia Research, Biopharmaceuticals and Biotechnology Research): Global Opportunity Analysis and Industry Forecast, 2019-2026

About Us:                         

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

Contact:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.